8-KItem 5.02 · Officer/Director ChangeItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
CVS HEALTH Corp (CVS)

CVS appoints JPMorgan executive to board as Larry Robbins departs

Filed with the SEC on · Summarized by InvestorsBot

CVS Health appointed Teresa Heitsenrether, JPMorgan Chase’s chief data and analytics officer, to its board effective November 18, 2026. Larry Robbins, a board member since 2024 who served on the Audit and Public Policy and External Affairs committees, left the board effective August 13, 2026; the company said Heitsenrether’s experience in data, artificial intelligence, technology transformation and financial services will support its strategy.

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from CVS HEALTH Corp

CVS names JPMorgan executive Teresa Heitsenrether to board

8-K · August 17, 2026

CVS Health raises 2026 guidance after second-quarter revenue and earnings growth

8-K · August 5, 2026

CVS Health ($CVS) elected John E.

8-K · March 19, 2026

CVS filed Form 8‑K (Item 9.01) on Feb 10, 2026 — exhibits: Press Release (Ex.

8-K · February 10, 2026

On Feb 10, 2026 CVS Health issued a press release with results for the three months and full year ended…

8-K · February 10, 2026